Sign in
TOP STORIES
Breaking News
Pharma Edupoint
Drug Approvals
Pharmaceutical Updates
Global Health
Dose daily
Career & Exams
Upcoming Workshop
Past Webinar
Industries
Legacies
Event Now
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Privacy Policy
Password recovery
Recover your password
your email
Search
TOP STORIES
Breaking News
Pharma Edupoint
Drug Approvals
Pharmaceutical Updates
Global Health
Dose daily
Career & Exams
Upcoming Workshop
Past Webinar
Industries
Legacies
Event Now
Search here...
Search
Subscribe
TOP STORIES
Breaking News
Pharma Edupoint
Drug Approvals
Pharmaceutical Updates
Global Health
Dose daily
Career & Exams
Upcoming Workshop
Past Webinar
Industries
Legacies
Event Now
Search here...
Search
Dose Daily News Bureau
facebook
instagram
linkedin
Exclusive Content
India Moves Closer to Affordable Weight-Loss Therapy as Sun Pharma Wins DCGI Nod for Semaglutide
Dose daily
Dose Daily News Bureau
-
January 24, 2026
Delhi High Court Allows Sale of Zydus’s Nivolumab Biosimilar Ahead of Patent Expiry
Dose daily
Dose Daily News Bureau
-
January 14, 2026
Urgent Drug Safety Alert : Telangana Drug Authorities Warn Public to Stop Using Almont-Kid Syrup
Dose daily
Dose Daily News Bureau
-
January 12, 2026
ICMR Notifies Amended HRD Scheme Guidelines Under Health Research Programmes
Dose daily
Dose Daily News Bureau
-
January 9, 2026
India Gets a New Hepatitis-E Vaccination Hevaxin by Dr. Reddy’s
Dose daily
Dose Daily News Bureau
-
January 8, 2026
Aurobindo Pharma’s Strategic Move: Acquires Khandelwal Labs Non-Oncology Prescription Business
Dose daily
Dose Daily News Bureau
-
January 6, 2026
1
...
26
27
28
...
41
Page 27 of 41
I want in
I've read and accept the
Privacy Policy
.
ICMR & NCDC Supports Kerala in Managing Nipah Case
Dose Daily News Bureau
-
June 15, 2026
FSSAI Bans Use of Metallic Pins and Wires in Food Packaging
Breaking News
Novo Nordisk Hit by an IT Security Breach: Pharma Giant Confronts Cyber Threats
Breaking News
Hair Color Brands Must Meet New CDSCO Regulations Under Latest Order
Breaking News
FDA Grants Accelerated Approval to Sanofi’s Tzield® for Pediatric Stage 3 Type 1 Diabetes
Breaking News
The FDA has outlined its updated strategy for generic drug oversight
Breaking News
×